Adaptive Biotechnologies

ADPT

Market cap $2.75B

Buy

Hold

Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$19.25

7% upside

High target

positive

1 neutral

25%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Morgan Stanley Tejas Savant				11 Nov ‘25 2 months ago
JP Morgan Rachel Vatnsdal 100% 1-yr ADPT win rate				6 Nov ‘25 2 months ago
BTIG Mark Massaro 100% 1-yr ADPT win rate				6 Nov ‘25 2 months ago
Piper Sandler David Westenberg 100% 1-yr ADPT win rate				15 Oct ‘25 3 months ago